Skip to content

Prof Ian Gilbert

identifying new drugs for unmet medical needs

  • Home
  • Leishmaniasis
  • Malaria
  • Biography
  • News
  • Publications
    • Key Publications
    • 2018
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
    • 2011
    • 2010
    • 2009
    • 2008
    • 2007
    • 2006
    • 2005
    • 2004
    • 2003
    • 2002
    • 2001
    • 2000
    • Pre-2000
  • Gallery
  • Contact

Key Publications

Ian Gilbert pulbications in Google scholar

 

 

 

Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis
Nature, 2018, 560 192-197 nature60

Challenges and recent progress in drug discovery for tropical diseases
Nature, 2015, 559, 498-506 nature60

A novel multiple-stage antimalarial agent that inhibits protein synthesis
Nature, 2015, 522, 315-320 nature60

Lead Optimization of a Pyrazole Sulfonamide Series of Trypanosoma brucei N-Myristoyltransferase Inhibitors: Idenification and Evaluation of CNS Penetrant Compounds as Potential Treatments for Stage 2 Human African Trypanosomiasis
J Med. Chem, 2014, 57, 9855-9869 JMedChem

 

Automated design of ligands to polypharmacological profiles
Nature, 2012, 492, 215-22 nature60

Design, Synthesis and Biological Evaluation of Trypanosoma brucei Trypanothione Synthetase Inhibitors
ChemMedChem, 2012, 7, 95-106  ChemMedChem-60

N-myristoyltransferase inhibitors as new leads to treat sleeping sickness
Nature, 2010, 464, 728-732  nature60

Proudly powered by WordPress